Skip to main content

Advertisement

SpringerLink
Log in

The effect of montmorillonite in graphene oxide/chitosan nanocomposite on controlled release of gemcitabine

  • Original Paper
  • Published:
Polymer Bulletin Aims and scope Submit manuscript

Abstract

In this study, a system was investigated for controlled delivery of gemcitabine (GEM), an anti-cancer drug with short biological half-life time (8–17 min), using graphene oxide (GO)/montmorillonite (MMT)/chitosan (CS) nanocomposite. The structure, morphology, zeta potential, and thermal stability of the nanocomposite were evaluated by FT-IR, XRD, zeta potential analyzer, FESEM, and TGA. The results revealed that the GO interacted with positively charged GEM and CS surface. Also, the drug was intercalated between the silicate layers of MMT, and this phenomenon is responsible for more protection of the drug from burst release. The positive zeta potential of GO/GEM/CS/MMT nanocomposite (+ 16.5 mV) promotes physical stability and interaction with the negative domains of the cell membrane. A significant synergistic effect of GO and MMT on the controlled release of GEM from the drug delivery system-based chitosan matrix has been obtained. The nanocomposite with 17 wt% MMT in the release media with pH of 7.4 provided the optimal combination of drug release rate and drug release content, whereas the time for GEM 50% release (T50%) was obtained about 2 h. The non-Fickian diffusion mechanism and Korsmeyer–Peppas kinetic model were confirmed for release of GEM from drug-loaded nanocomposites. Finally, to investigate the efficiency of nanocomposite as an anti-cancer drug delivery system, an in vitro cytotoxicity assay was also carried out using breast cancer cell line MDA-MB-231. Results confirmed that the prepared nanocomposite could be used as a potential breast cancer therapy system for the controlled delivery of GEM.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and materials

Not applicable.

Code availability

Not applicable.

References

  1. Yang Y, Jiang J, Du B, Gan ZF, Qian M, Zhang P (2009) Preparation and properties of a novel drug delivery system with both magnetic and bimolecular targeting. J Mater Sci Mater Med 20:301–307

    Article  CAS  PubMed  Google Scholar 

  2. Zhang D, Lv P, Zhou C, Zhao Y, Liao X, Yang B (2019) Cyclodextrin-based delivery systems for cancer treatment. Mater Sci Eng C 96:872–886

    Article  CAS  Google Scholar 

  3. Li N, Zhao L, Qi L, Li Z, Luan Y (2016) Polymer assembly: promising carriers as co-delivery systems for cancer therapy. Prog Polym Sci 58:1–26

    Article  CAS  Google Scholar 

  4. Huang P, Plunkett W (1995) Fludarabine-and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Can Chemother Pharmacol 36:181–188

    Article  CAS  Google Scholar 

  5. Parsian M, Unsoy G, Mutlu P, Yalcın S, Tezcaner A, Gunduz U (2016) Loading of gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug. Eur J Pharmacol 5:121–128

    Article  Google Scholar 

  6. Safdar R, Omar AA, Arunagiri A, Regupathi I, Thanabalan M (2019) Potential of Chitosan and its derivatives for controlled drug release applications—a review. J Drug Deliv Sci Technol 49:642–659

    Article  CAS  Google Scholar 

  7. Liu Z, Robinson JT, Tabakman SM, Yang K, Dai H (2011) Carbon materials for drug delivery and cancer therapy. Mater Today 14:316–323

    Article  CAS  Google Scholar 

  8. Bekaroğlu MG, Nurili F, İşçi S (2018) Montmorillonite as imaging and drug delivery agent for cancer therapy. Appl Clay Sci 162:469–477

    Article  Google Scholar 

  9. Shi Y, Xiong Z, Lu X, Yan X, Cai X, Xue W (2016) Novel carboxymethyl chitosan-graphene oxide hybrid particles for drug delivery. J Mater Sci Mater Med 27:169

    Article  PubMed  Google Scholar 

  10. Pan Q, Lv Y, Williams GR, Tao L, Yang H, Li H, Zhu L (2016) Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. Carbohydr Polym 151:812–820

    Article  CAS  PubMed  Google Scholar 

  11. Zhang H, Yan T, Xu S, Feng S, Huang D, Fujita M, Gao XD (2017) Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides. Mater Sci Eng C 37:144–151

    Article  Google Scholar 

  12. Bernkop-Schnürch A, Dünnhaupt S (2012) Chitosan-based drug delivery systems. Eur J Pharm Biopharm 3:463–469

    Article  Google Scholar 

  13. Zhang H, Chen S, Zhi C, Yamazaki T, Hanagata N (2013) Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines. Int J Nanomed 8:1783–1793

    Google Scholar 

  14. Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, Li J, Gan LH (2011) Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 11:1569–1578

    Article  Google Scholar 

  15. Zhang SA, Yang K, Feng LZ, Liu Z (2011) In vitro and in vivo behaviors of dextran functionalized graphene. Carbon 12:4040–4049

    Article  Google Scholar 

  16. Yadav M, Ahmad S (2015) Montmorillonite/graphene oxide/chitosan composite: synthesis, characterization and properties. Int J Biol Macromol 79:923–933

    Article  CAS  PubMed  Google Scholar 

  17. Georgakilas V, Otyepka M, Bourlinos AB, Chandra V, Kim N, Kemp KC, Hobza P, Zboril R, Kim KS (2012) Functionalization of graphene: covalent and non-covalent approaches. Deriv Appl Chem Rev 112(11):6156–6214

    CAS  Google Scholar 

  18. Zhang C, Tjiu WW, Fan W, Yang Z, Huang S, Liu TX (2011) Aqueous stabilization of graphene sheets using exfoliated montmorillonite nanoplatelets for multifunctional free-standing hybrid films via vacuum-assisted self-assembly. J Mater Chem 21(44):18011–18017

    Article  CAS  Google Scholar 

  19. Prashanth SN, Teradal NL, Seetharamappa J, Satpati AK, Reddy AVR (2014) Fabrification of electroreduced graphene oxide−bentonite sodium composite modified electrode and its sensing application for linezolid. Electrochim Acta 133:49–56

    Article  CAS  Google Scholar 

  20. Farshi Azhar F, Olad A (2014) A study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate–chitosan/montmorillonite nanocomposite systems. Appl Clay Sci 101:288–296

    Article  CAS  Google Scholar 

  21. Liu Q, Liu Y, Xiang S, Mo X, Su S, Zhang J (2011) Apoptosis and cytotoxicity of oligo (styrene-co-acrylonitrile)-modified montmorillonite. Appl Clay Sci 51:214–219

    Article  CAS  Google Scholar 

  22. Kevadiya BD, Patel TA, Jhala DD, Thumbar RP, Brahmbhatt H, Pandya MP, Rajkumar S, Jena PK, Joshi GV, Gadhia PK, Tripathi CB, Bajaj HC (2012) Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU). Eur J Pharm Biopharm 81:91–101

    Article  CAS  PubMed  Google Scholar 

  23. Darder M, Colilla M, Ruiz-Hitzky E (2003) Biopolymer-clay nanocomposites based on chitosan intercalated in montmorillonite. Chem Mater 15:3774–3780

    Article  CAS  Google Scholar 

  24. Derakhshandeh K, Fathi S (2012) Role of chitosan nanoparticles in the oral absorption of Gemcitabine. Int J Pharm 437:172–177

    Article  CAS  PubMed  Google Scholar 

  25. Betsiou M, Bantsis G, Zoi I, Sikalidis C (2012) Adsorption and release of gemcitabine hydrochloride and oxaliplatin by hydroxyapatite. Ceram Int 38:2719–2724

    Article  CAS  Google Scholar 

  26. Betsiou M, Bantsis G, Sikalidis C (2013) Loading and delivery of anticancer drugs using montmorillonite. Int J Appl Ceram Technol 11:92–99

    Article  Google Scholar 

  27. Garg NK, Dwivedi P, Campbell C, Tyagi RK (2012) Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention. Eur J Pharm Sci 47:1006–1014

    Article  CAS  PubMed  Google Scholar 

  28. Wade SJ, Zuzic A, Foroughi J, Talebian S, Aghmesheh M, Moulton SE, Vine KL (2017) Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: towards localized drug delivery for the treatment of pancreatic cancer. Pancreatology 17:795–804

    Article  CAS  PubMed  Google Scholar 

  29. Chen G, Svirskis D, Lu W, Ying M, Huang Y, Wen J (2018) N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer. J Control Release 277:142–153

    Article  CAS  PubMed  Google Scholar 

  30. Xing J, Deng L, Dong A (2010) Chitosan/alginate nanoparticles stabilized by poloxamer for the controlled release of 5-fluorouracil. J Appl Polym Sci 117:2354–2359

    Article  CAS  Google Scholar 

  31. Higuchi T (1963) Mechanism of sustained medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 84:1464–1477

    Google Scholar 

  32. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35

    Article  CAS  Google Scholar 

  33. Serra L, Doménech J, Peppas NA (2006) Drug transport mechanisms and release kinetics from molecularly designed poly (acrylic acid- g-ethylene glycol) hydrogels. Biomaterials 27:5440–5451

    Article  CAS  PubMed  Google Scholar 

  34. Costa P, Sousa Lobo JM (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–133

    Article  CAS  PubMed  Google Scholar 

  35. Pasparakis G, Bouropoulos N (2006) Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm 323:34–42

    Article  CAS  PubMed  Google Scholar 

  36. Farshi Azhar F, Olad A, Salehi R (2014) Fabrication and characterization of chitosan–gelatin/nanohydroxyapatite–polyaniline composite with potential application in tissue engineering scaffolds. Des Monomers Polym 17:654–667

    Article  CAS  Google Scholar 

  37. Olad A, Farshi Azhar F (2014) A study on the adsorption of chromium (VI) from aqueous solutions on the alginate-montmorillonite/polyaniline nanocomposite. Desalin Water Treat 52:2548–2559

    Article  CAS  Google Scholar 

  38. Iglesias GR, Reyes-Ortega F, Fernandez Ch, Delgado A (2018) Hyperthermia-triggered gemcitabine release from polymer-coated magnetite nanoparticles. Polymers 10(269):430–445

    Google Scholar 

  39. Olad A, Bakht Khosh Hagh H, Mirmohseni A, Farshi Azhar F (2019) Graphene oxide and montmorillonite enriched natural polymeric scaffold for bone tissue engineering. Ceram Int 45:15609–15619

    Article  CAS  Google Scholar 

  40. Olad A, Farshi Azhar F (2014) The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan–gelatin/nanohydroxyapatite–montmorillonite scaffold for bone tissue engineering. Ceram Int 40:10061–10072

    Article  CAS  Google Scholar 

  41. Ogawa K, Hirano S, Miyanishi T, Yui T, Watanabe T (1984) A new polymorph of chitosan. Macromolecules 17:973–975

    Article  CAS  Google Scholar 

  42. Farshi Azhar F, Olad A, Mirmohseni A (2014) Development of novel hybrid nanocomposites based on natural biodegradable polymer–montmorillonite/polyaniline: preparation and characterization. Polym Bull 71:1591–1610

    Article  CAS  Google Scholar 

  43. Arya G, Vandana M, Acharya S, Sahoo SK (2011) Enhanced antproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomed Nanotechnol 7:859–870

    Article  CAS  Google Scholar 

  44. Wang SF, Shen L, Tong YJ, Chen L, Phang IY, Lim PQ, Liu TX (2005) Biopolymer chitosan/montmorillonite nanocomposites: preparation and characterization. Polym Degrad Stab 90:123–131

    Article  CAS  Google Scholar 

  45. Karimtehrani M, Ehsani NP, Ghasemi I (2017) Functionalization of graphene nanoplatelet and the shape memory properties of nanocomposite based on thermoplastic elastomer polyurethane/poly(vinyl chloride)/graphene nanoplateletes. Iran J Polym Sci Technol (Persian) 30:287–297

    Google Scholar 

  46. Hunter RJ (2013) Zeta potential in colloid science: principles and applications. Academic Press, Cambridge

    Google Scholar 

  47. Chow EKH, Ho D (2013) Cancer nanomedicine: from drug delivery to imaging. Sci Transl Med 5:216rv214

    Article  Google Scholar 

  48. He C, Yin L, Tang C, Yin C (2012) Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials 33:8569–8578

    Article  CAS  PubMed  Google Scholar 

  49. Win KY, Feng SS (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–2722

    Article  CAS  PubMed  Google Scholar 

  50. Seema Monika Datta SM (2013) Clay–polymer nanocomposites as a novel drug carrier: synthesis, characterization and controlled release study of propranolol hydrochloride. Appl Clay Sci 80–81:85–92

    Article  Google Scholar 

  51. Malekmohammadi S, Hadadzadeh H, Farrokhpour H, Amirghofran Z (2018) Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery. Soft Matter 14:2400–2410

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are most grateful the continuing financial support of this research project by the Azarbaijan Shahid Madani University.

Funding

The authors declare that there is no funding regarding the publication of this article.

Author information

Authors and Affiliations

  1. Applied Polymer Research Laboratory, Department of Chemistry, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran

    Fahimeh Farshi Azhar & Mehrnoush Rezaei

  2. Polymer Composite Research Laboratory, Department of Applied Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran

    Ali Olad

  3. Department of Medical Biotechnology, Faculty of Advanced Medical Science and Drug Applied Research Center, Tabriz University of Medical Science, Tabriz, Iran

    Hanieh Mousazadeh

Authors
  1. Fahimeh Farshi Azhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehrnoush Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Olad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanieh Mousazadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Not applicable.

Corresponding author

Correspondence to Fahimeh Farshi Azhar.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farshi Azhar, F., Rezaei, M., Olad, A. et al. The effect of montmorillonite in graphene oxide/chitosan nanocomposite on controlled release of gemcitabine. Polym. Bull. 79, 5861–5883 (2022). https://doi.org/10.1007/s00289-021-03774-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00289-021-03774-y

Keywords

Search

Navigation